有证据表明,抗抑郁药因抗抑郁药增加了五种精神疾病的风险
Lu Hou1, Zhiqiang Du2, Rongrong Lu2
1Department of Psychiatry, Huai'an Third People's Hospital, Huai'an, 223021, Jiangsu, China.
European archives of psychiatry and clinical neuroscience
|October 30, 2025
概括
抗抑郁药 (ATDs) 可能因果性地增加精神疾病的风险,包括,精神分裂症,强迫症,药物滥用以及自杀或自伤. 需要进一步的研究来平衡ATD的好处与这些潜在风险.
科学领域:
- 精神病学遗传学 精神病学遗传学
- 药物基因组学 药物基因组学
- 流行病学 流行病学
背景情况:
- 抗抑郁药 (ATD) 的使用与精神疾病有关.
- ATD与精神疾病之间的因果关系尚不清楚.
- 遗传学研究提供了对潜在因果关系的见解.
研究的目的:
- 调查ATD与五种精神疾病之间的因果关系.
- 使用双样本孟德尔随机化 (TSMR) 方法.
- 评估 (CONV),精神分裂症 (SCZ),强迫症 (OCD),药物滥用 (SA) 和自杀或自我伤害 (SOSH) 的因果关系.
主要方法:
- 两个样本的孟德尔随机化 (TSMR) 分析.
- 首要因果关系评估的反变量加权 (IVW) 方法.
- 权重中位数,权重模式和MR Egger方法用于验证.
- 灵敏度分析包括MR-Egger拦截,Cochran的Q和离开一个的测试,以检测异质性和性.
主要成果:
- 在基因预测的ATD和CONV,SCZ,OCD,SA和SOSH之间发现了显著的积极因果关系.
- 特定的赔率比率 (OR) 和置信区间 (CI) 强调了这些关联的强度.
- 敏感性分析证实了研究结果的稳定性和可靠性.
结论:
- 抗抑郁药物 (ATD) 被确定为CONV,SCZ,强迫症,SA和SOSH的潜在风险因素.
- 临床实践需要对ATD治疗效果与潜在风险进行全面评估.
- 对于使用ATD的患者,建议制定个性化治疗计划和提高临床警.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Diagnostic and Statistical Manual of Mental Disorders (DSM)
1.0K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.0K
Depressive Disorders: Etiology
428
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
428
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Attention-Deficit/Hyperactivity Disorder
733
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
733


